» Articles » PMID: 19724248

Neurological Complications of Chronic Kidney Disease

Overview
Journal Nat Rev Neurol
Specialty Neurology
Date 2009 Sep 3
PMID 19724248
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) is a critical and rapidly growing global health problem. Neurological complications occur in almost all patients with severe CKD, potentially affecting all levels of the nervous system, from the CNS through to the PNS. Cognitive impairment, manifesting typically as a vascular dementia, develops in a considerable proportion of patients on dialysis, and improves with renal transplantation. Patients on dialysis are generally weaker, less active and have reduced exercise capacity compared with healthy individuals. Peripheral neuropathy manifests in almost all such patients, leading to weakness and disability. Better dialysis strategies and dietary modification could improve outcomes of transplantation if implemented before surgery. For patients with autonomic neuropathy, specific treatments, including sildenafil for impotence and midodrine for intradialytic hypotension, are effective and well tolerated. Exercise training programs and carnitine supplementation might be beneficial for neuromuscular complications, and restless legs syndrome in CKD responds to dopaminergic agonists and levodopa treatment. The present Review dissects the pathophysiology of neurological complications related to CKD and highlights the spectrum of therapies currently available.

Citing Articles

Prediction models for ischemic stroke and bleeding in dialysis patients: a systematic review and meta-analysis.

Travlos C, Chirgwin-Dasgupta A, Trinh E, Sniderman A, Alam A, Mavrakanas T Clin Kidney J. 2025; 17(12):sfae347.

PMID: 39981320 PMC: 11841370. DOI: 10.1093/ckj/sfae347.


Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysis.

Merlino L, Rainone F, Chinnadurai R, Hernandez G, Tollitt J, Battini G Clin Kidney J. 2025; 18(1):sfae401.

PMID: 39866298 PMC: 11761004. DOI: 10.1093/ckj/sfae401.


Vitamin B12 deficiency in dialysis patients: risk factors, diagnosis, complications, and treatment: A comprehensive review.

Araji G, Keesari P, Chowdhry V, Valsechi-Diaz J, Afif S, Diab W World J Nephrol. 2024; 13(4):100268.

PMID: 39723360 PMC: 11572648. DOI: 10.5527/wjn.v13.i4.100268.


Unraveling the association between chronic inflammatory demyelinating polyradiculoneuropathy and peritoneal Dialysis.

Chen Y, Chang T, Chen C BMC Nephrol. 2024; 25(1):383.

PMID: 39468467 PMC: 11514778. DOI: 10.1186/s12882-024-03830-5.


Peripheral Neuropathy Associated with Higher Mortality in Population with Chronic Kidney Disease: National Health and Nutrition Examination Surveys.

Cai X, Li W, Ge S, Xu G Kidney Dis (Basel). 2024; 10(2):79-88.

PMID: 38751792 PMC: 11095618. DOI: 10.1159/000535481.


References
1.
Mendley S, Zelko F . Improvement in specific aspects of neurocognitive performance in children after renal transplantation. Kidney Int. 1999; 56(1):318-23. DOI: 10.1046/j.1523-1755.1999.00539.x. View

2.
Kurella M, Mapes D, Port F, Chertow G . Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2006; 21(9):2543-8. DOI: 10.1093/ndt/gfl275. View

3.
Guarnieri G, Grassi G, Barazzoni R, Zanetti M, Biolo G . The impact of inflammation on metabolic regulation in chronic kidney disease: a review. J Ren Nutr. 2005; 15(1):121-4. DOI: 10.1053/j.jrn.2004.09.016. View

4.
Vermeer S, Prins N, den Heijer T, Hofman A, Koudstaal P, Breteler M . Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348(13):1215-22. DOI: 10.1056/NEJMoa022066. View

5.
Hattan E, Chalk C, Postuma R . Is there a higher risk of restless legs syndrome in peripheral neuropathy?. Neurology. 2008; 72(11):955-60. DOI: 10.1212/01.wnl.0000336341.72621.db. View